US Stock MarketDetailed Quotes

Madrigal Pharmaceuticals (MDGL)

Watchlist
  • 311.140
  • -8.730-2.73%
Close Jul 15 15:59 ET
  • 306.140
  • -5.000-1.61%
Pre 04:22 ET
6.91BMarket Cap-17.44P/E (TTM)

Madrigal Pharmaceuticals (MDGL) Key Financial Indicators

MDGL Earnings per Share (EPS)

According to the latest financial report of Madrigal Pharmaceuticals, the latest earnings per share (TTM) for the company is -3.32. Investing in companies with strong earnings per share can potentially provide higher returns.

Currency: USD

Quarterly

Loading...

MDGL Free Cash Flow (FCF)

Interested in knowing about Madrigal Pharmaceuticals's free cash flow? The latest report shows it as -88.89M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.

Currency: USD

Quarterly

Loading...

MDGL Current Ratio

If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Madrigal Pharmaceuticals shows that the company's current ratio is 5.91, indicating healthy liquidity.

Currency: USD

Quarterly

Loading...

MDGL Quick Ratio

Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Madrigal Pharmaceuticals, the quick ratio is 5.41, indicating that the company can meet its short-term debt obligations.

Currency: USD

Quarterly

Loading...

MDGL Return on Equity (ROE)

Want to learn more about the financial health of Madrigal Pharmaceuticals? The latest ROE figure is -10.00%, indicating that the company has stable profitability.

Currency: USD

Quarterly

Loading...

MDGL Return on Assets (ROA)

Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Madrigal Pharmaceuticals, the total asset return on investment (ROA) is -7.18%.

Currency: USD

Quarterly

Loading...

MDGL Gross Margin

Gross margin can provide insight into a company's pricing strategy and cost structure. Check Madrigal Pharmaceuticals's latest financial report to see how their gross margin is doing - currently at 96.71%.

Currency: USD

Quarterly

Loading...

MDGL Net Margin

For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Madrigal Pharmaceuticals, the net profit margin is -53.36%, which is a good sign for its profitability.

Currency: USD

Quarterly

Loading...

Market Insights

Tariff Storm Hits: Hedge with ETFs? Tariff Storm Hits: Hedge with ETFs?

The U.S. has sparked a tariff storm, triggering global market volatility. When the market fluctuates violently, more investment opportunities often appear. Compared with choosing individual stocks, investing in ETFs of the broader market can more easily capture opportunities for market reversals. Disclaimer: Among the U.S. stock market index ETFs: EFF, which is in the top 3 in terms of asset size among the fear index ETFs; the top 3 ETFs in terms of asset size among the S&P 500 index ETFs; and the corresponding leveraged ETFs; the top 4 ETFs in terms of asset size among the Nasdaq ETFs; and the top 3 ETFs in terms of asset size among the Dow Jones Index. This presentation is for informational and educational use only and is not a recommendation or endorsement of any particular investment or investment strategy. Investment information provided in this content is general in nature, strictly for illustrative purposes, and may not be appropriate for all investors. It is provided without respect to individual investors' financial sophistication, financial situation, investment objectives, investing time horizon, or risk tolerance. You should consider the appropriateness of this information having regard to your relevant personal circumstances before making any investment decisions. Past investment performance does not indicate or guarantee future success. Returns will vary, and all investments carry risks, including loss of principal. FUTU makes no representation or warranty as to its adequacy, completeness, accuracy or timeline for any particular purpose of the above content. Instutional holding and portfolio information provided is based data in 13f filings. The composition provided is updated on a significant delay and may be incomplete. It is not possible to replicate the timing or exact holdings and portfolios. The U.S. has sparked a tariff storm, triggering global market volatility. When the market fluctuates violently, more investment opportunities often appear. Compared with choosing individual stocks, investing in ETFs of the broader market can more easily capture opportunities for market reversals. Disclaimer: Among the U.S. stock market index ETFs: EFF, which is in the top 3 in terms of asset size among the fear index ETFs; the top 3 ETFs in terms of asset size among the S&P 500 index ETFs; and the corresponding leveraged ETFs; the top 4 ETFs in terms of asset size among the Nasdaq ETFs; and the top 3 ETFs in terms of asset size among the Dow Jones Index. This presentation is for informational and educational use only and is not a recommendation or endorsement of any particular investment or investment strategy. Investment information provided in this content is general in nature, strictly for illustrative purposes, and may not be appropriate for all investors. It is provided without respect to individual investors' financial sophistication, financial situation, investment objectives, investing time horizon, or risk tolerance. You should consider the appropriateness of this information having regard to your relevant personal circumstances before making any investment decisions. Past investment performance does not indicate or guarantee future success. Returns will vary, and all investments carry risks, including loss of principal. FUTU makes no representation or warranty as to its adequacy, completeness, accuracy or timeline for any particular purpose of the above content. Instutional holding and portfolio information provided is based data in 13f filings. The composition provided is updated on a significant delay and may be incomplete. It is not possible to replicate the timing or exact holdings and portfolios.

Unlock Now

Discussing

Focus on tariff dynamics! How to plan most securely in the near future?
Recently, Trump's tariffs have sparked controversy again. Trump stated that the United States would impose a 100% tariff on Russia, a 30% ta Show More

focus on technology stocks

Top tech company strong as always.